Back to Experiences
Treatment

NMN

Ailments

Effectiveness Rating

This rating represents how effective the treatment was for this experience.

Certainty Level

This is the degree of certainty the user has that this outcome was produced by the treatment.

Cheek Dimple / Skin Fullness
★★★★★ (5/5)
90%
Chin Line / Wrinkles
★★★★★ (5/5)
85%

Side Effects Reported

None reported.

Severity

None

Experience Details

Raw-note based NMN experience for facial plumping, cheek dimple repair, and chin-line improvement. NMN stood out as a filler-like intervention when prepared properly. Dissolving one tablet in a small amount of water and applying it gave rapid plumping and fading on the treated side of the face, with the cheek dimple and chin line both improving. Two tablets in cold water continued to help in most areas, while hot water or paste-like preparation seemed much less effective. Topical use with DMSO also appeared to reduce the dimple and wrinkles around the eyes by plumping the area.

Daily Tracking Record

1 entry
Date Taken Recorded update Time: NMN
Dosage: 1000 mg

Rapid filler-like plumping to the cheek dimple and chin line. Cold-water liquid preparation appeared strongest, while hot-water or paste-like preparation seemed weaker. Topical use with DMSO also seemed to reduce facial dimpling and wrinkles by plumping the area.

Long-Term Outcomes

NMN stayed one of the strongest repeatable treatments for facial plumping and structural repair in these notes. Around 1000 mg gave the clearest improvement to the cheek dimple and chin line, especially when used in a liquid-friendly preparation, while hot-water or paste-like preparation seemed less reliable. It also paired well with the broader skin-repair stack rather than clearly competing with it.

HH
Health Hacker Jul 26, 2026 · Updated Sep 20, 2026
Important Disclaimer: This information is for educational purposes only. Consult a healthcare provider before making any health decisions.

Community Discussion (0)

Log in or register to join the discussion.

No comments yet. Be the first to share your thoughts.